Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849166) titled 'BRCC36 and Telomerase Levels in Women With Polycystic Ovary Syndrome' on Sept. 24.

Study Type: Observational

Primary Sponsor: Cumhuriyet University

Condition: Polycystic Ovarian Syndrome (PCOS)

Recruitment Status: Not recruiting

Date of First Enrollment: February 20, 2024

Target Sample Size: 60

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07849166

Published by HT Digital Content Services with permission from Health Daily Digest....